Dr. Lou Garrison is Interim Director and Professor in the Pharmaceutical Outcomes Research & Policy Program in the Department of Pharmacy and Adjunct Professor in the Departments of Global Health and Health Services at the University of Washington, where he joined the faculty in 2004. During 2012-3, he was on sabbatical as Visiting Senior Research Fellow at the Office of Health Economics in London. In the 12 years before joining UW, he worked as an economist in the pharmaceutical industry. In 2002-4, he was Vice President and Head of Health Economics & Strategic Pricing in Roche Pharmaceuticals, and was based in Basel, Switzerland. He oversaw the development of the economic and pricing strategies, and research plans for all Roche compounds. Prior to this, he was Director of the Project HOPE Center for Health Affairs. In eight years there, he worked on a wide variety of health policy issues, including studies of health care reform both in the U.S. and overseas. Before this, he worked at the Battelle Human Affairs Research Centers in Seattle, where he carried out studies of the adequacy of physician manpower supply and the cost-effectiveness of kidney and heart transplantation. He received a B.A. in economics from Indiana University, and a Ph.D. in economics from Stanford University. Dr. Garrison's research interests include national and international health policy issues related to pharmacogenomics and personalized medicine, regulatory benefit-risk analysis, insurance, pricing, reimbursement, and risk-sharing agreements, as well as the economic evaluation of pharmaceuticals, diagnostics, devices, surgical procedures, and vaccines, particularly as related to organ transplantation, renal disease, influenza, measles, obesity, and cancer. From 2007-9, he served on the Board of Directors of the International Society for Pharmacoeconomics and Outcomes Research. He currently chairs the ISPOR Health Science Policy Council.